Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 1998American Journal of Hematology

DAB389IL2 diphtheria fusion toxin produces clinical responses in tumor stage cutaneous T cell lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

MDMadeleine DuvicNorthwestern UniversityJCJennifer Clay CatherEngenderHealthJMJohn C. MaizeMedical University of South Carolina

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Duvic et al. (1998) studied this question.

synapsesocial.com/papers/6aa2a952da8566d019e56b00https://doi.org/10.1002/(sici)1096-8652(199805)58:1<87::aid-ajh18>3.0.co;2-2
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1An Anti-CD3 Single-chain Immunotoxin with a Truncated Diphtheria Toxin Avoids Inhibition by Pre-existing Antibodies in Human Blood1995 · 47 citations
  2. 2A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma1996 · 139 citations
  3. 3Structure/function analysis of interleukin-2-toxin (DAB486-IL-2). Fragment B sequences required for the delivery of fragment A to the cytosol of target cells.1990 · 186 citations
  4. 4Cloning of the γ Chain of the Human IL-2 Receptor1992 · 844 citations
  5. 5Interleukin-2 fusion protein: An investigational therapy for interleukin-2 receptor expressing malignancies1997 · 67 citations